Fulvestrant - NDC Database
0143-9022 Feb 10, 2022
Fulvestrant 50 mg/ml Intramuscular Injection by Hikma Pharmaceuticals USA Inc.
Fulvestrant 50 mg/ml Intramuscular Injection by Hikma Pharmaceuticals USA Inc.
0310-7720 Oct 08, 2019
Fulvestrant 50 mg/ml Intramuscular Injection by Astrazeneca Pharmaceuticals Lp
Fulvestrant 50 mg/ml Intramuscular Injection by Astrazeneca Pharmaceuticals Lp
25021-462 Aug 01, 2019
Fulvestrant 50 mg/ml Intramuscular Injection, Solution by Sagent Pharmaceuticals
Fulvestrant 50 mg/ml Intramuscular Injection, Solution by Sagent Pharmaceuticals
25021-471 Sep 15, 2024
Fulvestrant 50 mg/ml Intramuscular Injection, Solution by Sagent Pharmaceuticals
Fulvestrant 50 mg/ml Intramuscular Injection, Solution by Sagent Pharmaceuticals
43598-262 Dec 31, 2023
Fulvestrant 50 mg/ml Intramuscular Injection, Solution by Dr.reddy's Laboratories Inc
Fulvestrant 50 mg/ml Intramuscular Injection, Solution by Dr.reddy's Laboratories Inc
63323-715 May 20, 2019
Fulvestrant 50 mg/ml Intramuscular Injection, Solution by Fresenius Kabi USA, LLC
Fulvestrant 50 mg/ml Intramuscular Injection, Solution by Fresenius Kabi USA, LLC
68001-424 Aug 01, 2019
Fulvestrant 50 mg/ml Intramuscular Injection, Solution by Bluepoint Laboratories
Fulvestrant 50 mg/ml Intramuscular Injection, Solution by Bluepoint Laboratories
68001-484 Mar 01, 2021
Fulvestrant 250 mg/5ml Intramuscular Injection, Solution by Bluepoint Laboratories
Fulvestrant 250 mg/5ml Intramuscular Injection, Solution by Bluepoint Laboratories
68001-510 Aug 13, 2021
Fulvestrant 68001-510 50 mg/ml Intramuscular Injection by Bluepoint Laboratories
Fulvestrant 68001-510 50 mg/ml Intramuscular Injection by Bluepoint Laboratories
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.